Literature DB >> 20232214

Ultrastructural immunogold localization of nitric oxide synthase isoforms in rat and human eosinophils.

Rohit Saluja1, Rashmi Saini, Kalyan Mitra, Virendra K Bajpai, Madhu Dikshit.   

Abstract

The involvement of nitric oxide (NO) as both pro and anti-inflammatory agent in allergic, airway inflammatory, and asthmatic diseases and the active participation of eosinophils in such ailments have been previously suggested. NO modulates eosinophil number, migration and their survival. The microenvironment of NO synthase (NOS) in subcellular organelles determines its rate and efficiency of catalysis, which in turn influences NO generation at distinct intracellular locales. The present study was undertaken to assess the intracellular distribution of NOS isoforms by transmission electron microscopy followed by morphometric analysis in human and rat eosinophils. Rat eosinophils were explored in parallel, and since they are widely used as model systems to mimic human diseases, a comparative study on NOS localization patterns might provide useful information in deciphering NO role in diverse aspects of eosinophil-related inflammatory ailments. The results demonstrated predominance of neuronal NOS (nNOS) in the eosinophilic granules and even distribution of inducible NOS (iNOS) and nNOS in the cytoplasm and nucleus of human eosinophils. In rat eosinophils, however, iNOS was mainly localized in the eosinophilic granules and nucleus, while nNOS was distributed evenly in cytoplasm and nucleus. Distribution of endothelial NOS (eNOS) in eosinophils was scanty. Differences in NOS isoforms and their localization in human and rat cells might have implications in differential mode of catalysis and functional contribution to eosinophil physiology and pathology, warranting detailed investigations. The present study highlights species-specific differences in the relative abundance and distribution pattern of NOS isoforms in rat and human eosinophils, which should be considered cautiously in interpreting the rat data to humans.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20232214     DOI: 10.1007/s00441-010-0947-y

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  6 in total

Review 1.  Intestinal eosinophils: multifaceted roles in tissue homeostasis and disease.

Authors:  G Coakley; H Wang; N L Harris
Journal:  Semin Immunopathol       Date:  2021-03-26       Impact factor: 9.623

2.  Diabetes Mellitus Alters the Immuno-Expression of Neuronal Nitric Oxide Synthase in the Rat Pancreas.

Authors:  Bright Starling Emerald; Sahar Mohsin; Crystal D'Souza; Annie John; Hussain El-Hasasna; Shreesh Ojha; Haider Raza; Basel Al-Ramadi; Ernest Adeghate
Journal:  Int J Mol Sci       Date:  2022-04-29       Impact factor: 6.208

Review 3.  Contemporary understanding of the secretory granules in human eosinophils.

Authors:  Rossana C N Melo; Peter F Weller
Journal:  J Leukoc Biol       Date:  2018-05-11       Impact factor: 4.962

Review 4.  Neuronal Nitric Oxide Synthase (nNOS) in Neutrophils: An Insight.

Authors:  Rashmi Saini; Zaffar Azam; Leena Sapra; Rupesh K Srivastava
Journal:  Rev Physiol Biochem Pharmacol       Date:  2021       Impact factor: 5.545

5.  Role of α-crystallin B as a regulatory switch in modulating cardiomyocyte apoptosis by mitochondria or endoplasmic reticulum during cardiac hypertrophy and myocardial infarction.

Authors:  A Mitra; T Basak; K Datta; S Naskar; S Sengupta; S Sarkar
Journal:  Cell Death Dis       Date:  2013-04-04       Impact factor: 8.469

6.  NOS1-derived nitric oxide promotes NF-κB transcriptional activity through inhibition of suppressor of cytokine signaling-1.

Authors:  Mirza Saqib Baig; Sofia V Zaichick; Mao Mao; Andre L de Abreu; Farnaz R Bakhshi; Peter C Hart; Uzma Saqib; Jing Deng; Saurabh Chatterjee; Michelle L Block; Stephen M Vogel; Asrar B Malik; Marcia E L Consolaro; John W Christman; Richard D Minshall; Benjamin N Gantner; Marcelo G Bonini
Journal:  J Exp Med       Date:  2015-08-31       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.